A Multi-Center, Open-Label, Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy.
Phase of Trial: Phase II/III
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Lacosamide (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors UCB Pharma Inc
- 03 Aug 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 18 Sep 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History